Margarita Gutova, Jonathan C Hibbard, Eric Ma, Heini M Natri, Vikram Adhikarla, Nyam-Osor Chimge, Runxiang Qiu, Cu Nguyen, Elizabeth Melendez, Brenda Aguilar, Renate Starr, Holly Yin, Russel C Rockne, Masaya Ono, Nicholas E Banovich, Yate-Ching Yuan, Christine E Brown, Michael Kahn
INTRODUCTION: Despite aggressive standard-of-care therapy, including surgery, radiation, and chemotherapy, glioblastoma recurrence is almost inevitable and uniformly lethal. Activation of glioma-intrinsic Wnt/β-catenin signaling is associated with a poor prognosis and the proliferation of glioma stem-like cells, leading to malignant transformation and tumor progression. Impressive results in a subset of cancers have been obtained using immunotherapies including anti-CTLA4, anti-PD-1, and anti-PD-L1 or chimeric antigen receptor (CAR) T cell therapies...
2024: Frontiers in Immunology